Načítava sa...

Advertisement

INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

RTTNews | Pred 961 dňami

INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

(RTTNews) - Biotechnology company Inovio Pharmaceuticals Inc. (INO) announced Thursday positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.

In the first cohort of 21 participants, INO-3107 showed a statistically significant improvement in the clinical endpoint of the number of surgical interventions needed to control papilloma growth.

INO-3107 was also observed to be well-tolerated and immunogenic in the trial. INO-3107 received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) in July 2020.

INO-3107 was evaluated in a Phase 1/2 open-label, multicenter trial to assess its safety, tolerability, immunogenicity, and efficacy in 32 participants with HPV 6 and/or HPV 11-associated RRP.

Results from the second cohort of 11 patients are expected in the first half of 2023.

For More Such Health News, visit rttnews.com

Značky: INO

read more

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.

RTTNews | Pred 599 dňami

INOVIO Says FDA Grants Breakthrough Therapy Designation For INO-3107; Stock Up 15%

INOVIO Says FDA Grants Breakthrough Therapy Designation For INO-3107; Stock Up 15%

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for INO-3107 as a potential treatment for patients with Recurrent Respiratory Papillomatosis (RRP).

RTTNews | Pred 632 dňami

INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

Biotechnology company INOVIO Pharmaceuticals, Inc. (INO) announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.

RTTNews | Pred 849 dňami

INOVIO Announces Corporate Reorganization, Including Workforce Reduction, To Reduce Expenses

INOVIO Announces Corporate Reorganization, Including Workforce Reduction, To Reduce Expenses

Biotechnology company INOVIO (INO) announced Tuesday that it has implemented a corporate reorganization designed to extend its cash runway and to focus on key clinical programs with the goal to drive long-term growth.

RTTNews | Pred 1047 dňami

TSX Settles Lower As Trade Tensions Resurface

TSX Settles Lower As Trade Tensions Resurface

Despite hitting record highs earlier in the week, the Canadian market ended weak for a second straight day as trade tensions weighed on sentiment, prompting investors to tread cautiously on Friday.

RTTNews | Pred 9 h 46 min

Crude Oil Prices Slip On Friday

Crude Oil Prices Slip On Friday

Crude suffered a weekly loss of more than 1 percent due to uncertainty over U.S. President Donald Trump's tariffs and their likely impact on global growth and fuel demand.

RTTNews | Pred 14 h 24 min

Pound Drops As Trade Tensions Renew

Pound Drops As Trade Tensions Renew

The pound fell against its major counterparts in the New York session on Friday, as trade tensions escalated after the U.S. President accused China of violating trade agreement reached earlier this month.

RTTNews | Pred 14 h 25 min

Weighed Down By Tariff Uncertainty, Gold Slides

Weighed Down By Tariff Uncertainty, Gold Slides

The swift changes in successive US court rulings on tariffs and a softer inflation report caused a slide in gold price on Friday.

RTTNews | Pred 14 h 33 min

Podmienky | Ochrana osobných údajov | Mapa stránok | Site Map Calendar

& copy; 2025 Myfxbook Ltd. Všetky práva vyhradené.

UPOZORNENIE NA VYSOKÉ RIZIKO: Obchodovanie s devízami prináša vysokú úroveň rizika, ktoré nemusí byť vhodné pre všetkých investorov. Páka vytvára ďalšie riziká a straty. Než sa rozhodnete obchodovať s devízami, dôkladne zvážte svoje investičné ciele, úroveň skúseností a toleranciu voči riziku. Môžete prísť o časť alebo všetky svoje počiatočné investície. Neinvestujte peniaze, ktoré si nemôžete dovoliť stratiť. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Všetky údaje a informácie sú poskytované „tak, ako sú“. iba na informačné účely a nie je určené na obchodné účely alebo rady. Výkonnosť v minulosti neznamená výkonnosť v budúcnosti.